Catalyst Wire Dossier Catalyst Wire Dossier

GSK3008356

GSK3008356 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK3008356, covering 2019-01-15 to 2019-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects [Phase 1]

See pricing